跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet - TGA Drug Approval Details
Approvals
/
TGA
/
TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet
Approved
STANDARD
TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
525cc0a810329fe3
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
525cc0a810329fe3
Product Name
TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet
Artg Id
269194
Artg Name
TENOFOVIR LAPL tenofovir disoproxil phosphate 291 mg film-coated tablet
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2017-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
525cc0a810329fe3
Type
Standard
Back to TGA Approvals